Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions

Cancer Cell(2023)10.1016/j.ccell.2023.10.007Source: DataRank Database

The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 70 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access70 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 6.47)OA: hybridTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Patrick Smith ORCID,David A. Knorr ORCID,Jeffrey V. Ravetch ORCID,Juan C. Osorio ORCID

Live enrichment

PubMed:37977147 PMC:PMC10842210 OpenAlex:https://openalex.org/W4388735808

National Institutes of Health

Grant: R01CA244327

National Institutes of Health

Grant: UL1TR001866

National Cancer Institute

Grant: K08CA266740

National Cancer Institute

Grant: R35CA196620

Memorial Sloan-Kettering Cancer Center

Grant: P30 CA008748

National Institutes of Health

Grant: 5R01CA244327-04

Novel Transgenic Mouse Models Addressing Outstanding Translational Barriers in Antibody-Based Therapeutics

National Institutes of Health

Grant: 5UL1TR001866-07

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

National Institutes of Health

Grant: 5K08CA266740-04

Role of Fc Receptors in the Therapeutic Activity of Antibodies Targeting the CD47-SIRP-alpha axis

National Institutes of Health

Grant: 5R35CA196620-02

Molecular mechanisms of antibody-mediated immunotherapies

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Center for Advancing Translational Sciences

FWCI

6.47

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.ccell.2023.10.007

publisherhttps://doi.org/10.1016/j.ccell.2023.10.007

publisherhttps://api.elsevier.com/content/article/PII:S153561082300363X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S153561082300363X?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37977147

Fields of Study

Phagocytosis and Immune RegulationMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses03 medical and health sciences0302 clinical medicineHumansCD47 AntigenImmunotherapyMacrophagesNeoplasmsPhagocytosisReceptors, IgGAntibodiesAnimalsMice

MeSH Terms

AnimalsAntibodiesHumansImmunotherapyMacrophagesNeoplasmsPhagocytosisReceptors, IgGMiceCD47 Antigen

Keywords

AntibodyCD47ImmunologyAntibody-dependent cell-mediated cytotoxicityCancer researchMedicineMonoclonal antibodyPhagocytosisMacrophageAntibody engineeringinnate immunityFc receptorCancer ImmunotherapySirpαMiceMacrophagesNeoplasmsReceptors, IgGHumansAnimalsCD47 AntigenImmunotherapyArticleAntibodies

Sustainable Development Goals

SDG 0: Good health and well-being